Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies

Overview of attention for article published in Cardiovascular Diabetology, May 2014

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 6,017 followers.

TopBiochem: Safety and tolerability of canakinumab, an IL-1beta inhibitor, in type 2 diabetes mellitus patients: a... http://t.co/zI84kAux34

Diabetes2/Med: Safety and tolerability of canakinumab, an IL-1beta inhibitor, in type 2 diabetes mellitus patients... http://t.co/hFRtZz7r2g

Safety and tolerability of canakinumab, an IL-1beta inhibitor, in type 2 diabetes mellitus patients: a pooled analy http://t.co/LgP9dUBCNb

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.